Animal models for hepatitis C and related liver disease

Hepatology Research

Volumn 40, Issue 1, 2010, Pages 69-82

  Koike, Kazuhiko ^a   Moriya, Kyoji ^a   Matsuura, Yoshiharu ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Core protein; Hepatitis C; Hepatocellular carcinoma; Insulin resistance; Steatosis; Transgenic mouse

Indexed keywords

CORE PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; GLYCOPROTEIN E1; GLYCOPROTEIN E2; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1BETA; LIVER X RECEPTOR ALPHA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYPROTEIN; PROTEIN E6AP; PROTEIN PA 28 GAMMA; RETINOID X RECEPTOR ALPHA; SIGNAL PEPTIDASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

CHIMPANZEE; FATTY LIVER; HEPATITIS C; HEPATITIS C VIRUS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; LIPID METABOLISM; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCANDENTIA; SJOEGREN SYNDROME; TRANSGENIC MOUSE; VIRUS GENOME; VIRUS VIRULENCE;

EID: 77954350897     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00593.x     Document Type: Review

References (62)

1. Wakita T, Pietschmann T, Kato T. Production of infectious hepatitis c virus in tissue culture from a cloned viral genome. Nat Med 2005, 11:791-6.
2. Bradley DW. Studies of non-A, non-B hepatitis and characterization of the hepatitis C virus in chimpanzees. Curr Top Microbiol Immunol 2000, 242:1-23.
3. Walter E, Keist R, Niederöst B. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996, 24:1-5.
4. Mercer DF, Schiller DE, Elliott JF. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001, 7:927-33.
5. Elmowalid GA, Qiao M, Jeong SH. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc Natl Acad Sci USA 2007, 104:8427-32.
6. Folgori A, Capone S, Ruggeri L. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med 2006, 12:190-7.
7. Xie ZC, Riezu-Boj JI, Lasarte JJ. Transmission of hepatitis C virus infection to tree shrews. Virology 1998, 244:513-20.
8. Zhao X, Tang ZY, Klumpp B. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J Clin Invest 2002, 109:221-32.
9. Barth H, Cerino R, Arcuri M. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. J Virol 2005, 79:5774-85.
10. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of hepatitis C viruses. Implications for diagnosis, development and control of viral diseases. Hepatology 1991, 14:381-8.
11. Moradpour D, Penin F, Rice CM. Replication of hepatitis C virus. Nat Rev Microbiol 2007, 5:453-63.
12. Boulant S, Montserret R, Hope RG. Structural determinants that target the hepatitis C virus core protein to lipid droplets. J Biol Chem 2006, 281:22236-47.
13. Suzuki R, Sakamoto S, Tsutsumi T. Molecular determinants for subcellular localization of hepatitis C virus core protein. J Virol 2005, 79:1271-81.
14. Shirakura M, Murakami K, Ichimura T. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol 2007, 81:1174-85.
15. Miyamoto H, Moriishi K, Moriya K. Hepatitis C virus core protein induces insulin resistance through a PA28γ-dependent pathway. J Virol 2007, 81:1727-35.
16. Moriishi K, Okabayashi T, Nakai K. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. J Virol 2003, 77:10237-49.
17. Li X, Lonard DM, Jung SY, Malovannaya A. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell 2006, 124:381-92.
18. Saito I, Miyamura T, Ohbayashi A. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990, 87:6547-9.
19. Kiyosawa K, Sodeyama T, Tanaka E. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990, 12:671-5.
20. Yotsuyanagi H, Shintani Y, Moriya K. Virological analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 2000, 181:1920-8.
21. Moriya K, Yotsuyanagi H, Shintani Y. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997, 78:1527-31.
22. Moriya K, Fujie H, Shintani Y. Hepatitis C virus core protein induces hepatocellular carcinoma in transgenic mice. Nat Med 1998, 4:1065-8.
23. Tsutsumi T, Suzuki T, Moriya K. Intrahepatic cytokine expression and AP-1 activation in mice transgenic for hepatitis C virus core protein. Virology 2002, 304:415-24.
24. Tsutsumi T, Suzuki T, Moriya K. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice. Hepatology 2003, 38:820-8.
25. Moriishi K, Mochizuki R, Moriya K. Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA 2007, 104:1661-6.
26. Shintani Y, Fujie H, Miyoshi H. Hepatitis C virus and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004, 126:840-8.
27. Tanaka N, Moriya K, Kiyosawa K, Koike K, Aoyama T. Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: implications for HCV-associated hepatocarcinogenesis. Int J Cancer 2008, 122:124-31.
28. Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T. PPAR-α is essential for severe hepatic steatosis and hepatocellular carcinoma induced by HCV core protein. J Clin Invest 2008, 118:683-94.
29. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM, Lai MM. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 2006, 80:7199-207.
30. Pasquinelli C, Shoenberger JM, Chung J. Hepatitis C virus core and E2 protein expression in transgenic mice. Hepatology 1997, 25:719-27.
31. Koike K, Moriya K, Ishibashi K. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995, 76:3031-8.
32. Koike K, Moriya K, Yotsuyanagi H. Sialadenitis resembling Sjögren's syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997, 94:233-6.
33. Lerat H, Honda M, Beard MR. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002, 122:352-65.
34. Naas T, Ghorbani M, Alvarez-Maya I. Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2. J Gen Virol 2005, 86:2185-96.
35. Kamegaya Y, Hiasa Y, Zukerberg L. Hepatitis C virus acts as a tumor accelerator by blocking apoptosis in a mouse model of hepatocarcinogenesis. Hepatology 2005, 41:660-7.
36. Kawamura T, Furusaka A, Koziel MJ. Transgenic expression of hepatitis C virus structural proteins in the mouse. Hepatology 25:1014-21.
37. Honda A, Arai Y, Hirota N. Hepatitis C virus structural proteins induce liver cell injury in transgenic mice. J Med Virol 1999, 59:281-9.
38. Alonzi T, Agrati C, Costabile B. Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice. J Gen Virol 2004, 85:1509-20.
39. Frelin L, Brenndörfer ED, Ahlén G. The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease. Gut 2006, 55:1475-83.
40. Majumder M, Ghosh AK, Steele R. Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice. Virology 2002, 294:94-105.
41. Wakita T, Taya C, Katsume A. Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system. J Biol Chem 1998, 273:9001-6.
42. Koike K. Molecular basis of hepatitis C virus-associated hepatocarcinogenesis: lessons from animal model studies. Clin Gastroenterol Hepatol 2005, 3:S132-5.
43. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 1992, 15:572-7.
44. Moriya K, Nakagawa K, Santa T. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocellular carcinogenesis. Cancer Res 2001, 61:4365-70.
45. Moriya K, Todoroki T, Tsutsumi T. Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: analysis in transgenic mice and humans. Biophys Biochem Res Commun 2001, 281:1207-12.
46. Korenaga M, Wang T, Li Y. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005, 280:37481-8.
47. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005, 42:5-13.
48. Perlemuter G, Sabile A, Letteron P. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002, 16:185-94.
49. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 2007, 355:883-8.
50. Waris G, Felmlee DJ, Negro F, Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 2007, 81:8122-30.
51. Su AI, Pezacki JP, Wodicka L. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 2002, 99:15669-74.
52. McPherson S, Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis. J Hepatol 2008, 49:1046-54.
53. Bigger CB, Guerra B, Brasky KM. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004, 78:13779-92.
54. Koike K, Moriya K, Kimura S. Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis. J Gastroenterol Hepatol 2002, 17:394-400.
55. Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K. Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus. Mol Cell Biol 2003, 23:7498-509.
56. Moriya K, Shintani Y, Fujie H. Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan. Hepatol Res 2003, 25:371-6.
57. Miyanari Y, Atsuzawa K, Usuda N. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 2007, 9:1089-97.
58. Kapadia SB, Chisari FV. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad USA 2005, 102:2561-6.
59. Tsutsumi T, Suzuki T, Shimoike T. Interaction of hepatitis C virus core protein with retinoid X receptor-a modulates its transcriptional activity. Hepatology 2002, 35:937-46.
60. Peters JM, Cheung C, Gonzalez FJ. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand? J Mol Med 2005, 83:774-85.
61. Li Y, Boehning DF, Qian T, Popov VL, Weinman SA. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J 2007, 21:2474-85.
62. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-70.